5:29 PM
 | 
Oct 18, 2013
 |  BC Extra  |  Company News

Anacor jumps on damages award in contract dispute

Anacor Pharmaceuticals Inc. (NASDAQ:ANAC) gained $3.06 (28%) to $13.83 on Friday after announcing that an arbitrator awarded the company $100 million in damages as part of a contract dispute with Valeant Pharmaceuticals International Inc. (TSX:VRX;...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >